Articles by Marc Hauschild

UK poised to be biotech leader

The amount of capital invested alongside CVC into UK companies increased six-fold between 2010 and 2015 - image courtesy of Depositphotos.
The amount of capital invested alongside corporate venture capital (CVC) into UK companies increased six-fold between 2010 and 2015, marking a fundamental shift in how start-up British biotech is funded, new research has shown.